Alexander Gunn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alexander Gunn

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

F1000Research|March 12, 2020

Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling toolAlexander Gunn, Shashika Bandara, Gavin Yamey, et al.

Journal of the American Chemical Society|January 23, 2009

Structure of the biliverdin radical intermediate in phycocyanobilin:ferredoxin oxidoreductase identified by high-field EPR and DFTStefan Stoll, Alexander Gunn, Marcin Brynda, et al.

Biochemistry|June 19, 2010

Structural basis for hydration dynamics in radical stabilization of bilin reductase mutantsAmanda C Kohler, David D Gae, Michael A Richley, et al.

Gates Open Research|September 25, 2019

Developing new health technologies for neglected diseases: a pipeline portfolio review and cost modelRuth Young, Tewodros Bekele, Alexander Gunn, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

F1000Research|March 12, 2020

Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling toolAlexander Gunn, Shashika Bandara, Gavin Yamey, et al.

Journal of the American Chemical Society|January 23, 2009

Structure of the biliverdin radical intermediate in phycocyanobilin:ferredoxin oxidoreductase identified by high-field EPR and DFTStefan Stoll, Alexander Gunn, Marcin Brynda, et al.

Biochemistry|June 19, 2010

Structural basis for hydration dynamics in radical stabilization of bilin reductase mutantsAmanda C Kohler, David D Gae, Michael A Richley, et al.

Gates Open Research|September 25, 2019

Developing new health technologies for neglected diseases: a pipeline portfolio review and cost modelRuth Young, Tewodros Bekele, Alexander Gunn, et al.

Pageof 2